Brensocatib significantly reduced the rate of pulmonary exacerbations and slowed lung function decline in patients with ...

Brensocatib is Currently Under Priority Review with the U.S. Food and Drug Administration— BRIDGEWATER, N.J., April 23, 2025 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM ...

Pope Francis’ doctor is sharing new details about the 88-year-old pontiff's final hours, including why Francis wasn’t ...

Sign Up for Wine Spectator’s Free Email Newsletters and stay up-to-date with all things wine.